Sabine Bahn (original) (raw)
Sabine Bahn is a professor of Neurotechnology, Professor & Director of the Bahn Laboratory at The University of Cambridge, a Professor of Translational Neuropsychiatry at Erasmus Medical Centre Bahn's research in The Bahn laboratory at Cambridge is focused on researching the molecular basis of neuropsychiatric diseases; using molecular profiling methods to investigate abnormalities in tissues, blood and fluids; as well as developing new methods for diagnosing and treating psychiatric disorders, in particular focussing on schizophrenia and mood disorders. The Bahn laboratory is supported by laboratory facilities at the Department of Chemical Engineering and Biotechnology, Cambridge and has received funding through the Stanley Medical Research Institute (SMRI), in addition to being partnered
| Property | Value |
|---|---|
| dbo:abstract | Sabine Bahn is a professor of Neurotechnology, Professor & Director of the Bahn Laboratory at The University of Cambridge, a Professor of Translational Neuropsychiatry at Erasmus Medical Centre Bahn's research in The Bahn laboratory at Cambridge is focused on researching the molecular basis of neuropsychiatric diseases; using molecular profiling methods to investigate abnormalities in tissues, blood and fluids; as well as developing new methods for diagnosing and treating psychiatric disorders, in particular focussing on schizophrenia and mood disorders. The Bahn laboratory is supported by laboratory facilities at the Department of Chemical Engineering and Biotechnology, Cambridge and has received funding through the Stanley Medical Research Institute (SMRI), in addition to being partnered with the Stanley Program for Epidemiology, Prevention and Treatment of Schizophrenia (SPECTS). (en) |
| dbo:academicDiscipline | dbr:Neuropsychiatry dbr:Neurotechnology |
| dbo:institution | dbr:University_of_Cambridge dbr:Erasmus_MC |
| dbo:wikiPageExternalLink | https://www.cam.ac.uk/research/news/new-approach-to-drug-discovery-could-lead-to-personalised-treatment-of-neuropsychiatric-disorders |
| dbo:wikiPageID | 61171582 (xsd:integer) |
| dbo:wikiPageLength | 7201 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1047598104 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Department_of_Chemical_Engineering_and_Biotechnology,_University_of_Cambridge dbr:University_of_Cambridge dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:Neuropsychologists dbr:Myriad_Genetics dbr:NASDAQ dbr:Lucy_Cavendish_College,_Cambridge dbc:Academics_of_the_University_of_Cambridge dbr:Erasmus_MC dbr:Psychiatrist dbr:Royal_Society_of_Biology dbr:Neuropsychiatry dbr:Neurotechnology |
| dbp:fields | Neurotechnology and Neuropsychiatry (en) |
| dbp:name | Sabine Bahn MD, PhD, MRCPsych (en) |
| dbp:sign | Sabine Bahn (en) |
| dbp:source | https://www.cam.ac.uk/research/news/new-approach-to-drug-discovery-could-lead-to-personalised-treatment-of-neuropsychiatric-disorders |
| dbp:text | Psychiatric disorders are increasingly recognised as disorders of the whole body (en) |
| dbp:wikiPageUsesTemplate | dbt:Authority_control dbt:Cn dbt:Quote dbt:Infobox_scientist |
| dbp:workplaces | University of Cambridge, England; Erasmus Medical Centre in Rotterdam, The Netherlands (en) |
| dcterms:subject | dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:Neuropsychologists dbc:Academics_of_the_University_of_Cambridge |
| rdf:type | owl:Thing foaf:Person dbo:Person dul:NaturalPerson wikidata:Q19088 wikidata:Q215627 wikidata:Q5 wikidata:Q729 dbo:Animal dbo:Eukaryote dbo:Scientist dbo:Species schema:Person wikidata:Q901 |
| rdfs:comment | Sabine Bahn is a professor of Neurotechnology, Professor & Director of the Bahn Laboratory at The University of Cambridge, a Professor of Translational Neuropsychiatry at Erasmus Medical Centre Bahn's research in The Bahn laboratory at Cambridge is focused on researching the molecular basis of neuropsychiatric diseases; using molecular profiling methods to investigate abnormalities in tissues, blood and fluids; as well as developing new methods for diagnosing and treating psychiatric disorders, in particular focussing on schizophrenia and mood disorders. The Bahn laboratory is supported by laboratory facilities at the Department of Chemical Engineering and Biotechnology, Cambridge and has received funding through the Stanley Medical Research Institute (SMRI), in addition to being partnered (en) |
| rdfs:label | Sabine Bahn (en) |
| owl:sameAs | wikidata:Sabine Bahn https://global.dbpedia.org/id/A4gtW |
| prov:wasDerivedFrom | wikipedia-en:Sabine_Bahn?oldid=1047598104&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Sabine_Bahn |
| foaf:name | Sabine Bahn (en) MD, PhD, MRCPsych (en) |
| is dbo:wikiPageWikiLink of | dbr:Department_of_Chemical_Engineering_and_Biotechnology,_University_of_Cambridge dbr:Hay_Festival |
| is foaf:primaryTopic of | wikipedia-en:Sabine_Bahn |